AdAlta Competitors

AdAlta (ASX:1AD) and (CHV) (CNSX:CHV) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation.

Earnings and Valuation

This table compares AdAlta and (CHV)'s gross revenue, earnings per share (EPS) and valuation.

(CHV) has lower revenue, but higher earnings than AdAlta.

Profitability

This table compares AdAlta and (CHV)'s net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of current ratings and target prices for AdAlta and (CHV), as provided by MarketBeat.com.

Summary

AdAlta beats (CHV) on 1 of the 1 factors compared between the two stocks.

(DDXS) (OTCMKTS:DDXS) and AdAlta (ASX:1AD) are both health technology companies, but which is the better business? We will compare the two businesses based on the strength of their risk, profitability, earnings, dividends, institutional ownership, analyst recommendations and valuation.

Analyst Ratings

This is a breakdown of recent ratings for (DDXS) and AdAlta, as provided by MarketBeat.

Earnings and Valuation

This table compares (DDXS) and AdAlta's gross revenue, earnings per share and valuation.

(DDXS) has higher earnings, but lower revenue than AdAlta.

Profitability

This table compares (DDXS) and AdAlta's net margins, return on equity and return on assets.

Summary

AdAlta beats (DDXS) on 1 of the 1 factors compared between the two stocks.

AdAlta (ASX:1AD) and (PREV) (CNSX:PREV) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

Earnings & Valuation

This table compares AdAlta and (PREV)'s gross revenue, earnings per share (EPS) and valuation.

(PREV) has lower revenue, but higher earnings than AdAlta.

Profitability

This table compares AdAlta and (PREV)'s net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of current ratings and target prices for AdAlta and (PREV), as provided by MarketBeat.com.

Summary

AdAlta beats (PREV) on 1 of the 1 factors compared between the two stocks.

(TNGN) (OTCMKTS:TNGN) and AdAlta (ASX:1AD) are both health technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

Analyst Recommendations

This is a breakdown of current recommendations for (TNGN) and AdAlta, as provided by MarketBeat.com.

Profitability

This table compares (TNGN) and AdAlta's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares (TNGN) and AdAlta's gross revenue, earnings per share and valuation.

(TNGN) has higher earnings, but lower revenue than AdAlta.

Summary

AdAlta beats (TNGN) on 1 of the 1 factors compared between the two stocks.

138267 (COM.TO) (TSE:COM) and AdAlta (ASX:1AD) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for 138267 (COM.TO) and AdAlta, as reported by MarketBeat.

Profitability

This table compares 138267 (COM.TO) and AdAlta's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares 138267 (COM.TO) and AdAlta's gross revenue, earnings per share (EPS) and valuation.

138267 (COM.TO) has higher earnings, but lower revenue than AdAlta.

Summary

AdAlta beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.

AdAlta (ASX:1AD) and 17031 (CNSX:MYM) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, dividends, institutional ownership, profitability, valuation, analyst recommendations and risk.

Profitability

This table compares AdAlta and 17031's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of recent ratings and target prices for AdAlta and 17031, as reported by MarketBeat.com.

Earnings and Valuation

This table compares AdAlta and 17031's top-line revenue, earnings per share and valuation.

17031 has lower revenue, but higher earnings than AdAlta.

Summary

AdAlta beats 17031 on 1 of the 1 factors compared between the two stocks.